Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
SUNDAY, April 19, 2015 (HealthDay News) -- A new drug that boosts the immune system's cancer-fighting potential is showing early promise for some ...
“Our thinking about how to use the immune system to treat cancer began to change dramatically two decades ago, when the focus shifted from turning ...
PHILADELPHIA (TheStreet) -- Treatment with the cancer immunotherapy known as chimeric antigen receptor T cells, or CAR-T, was found to be ...
PHILADELPHIA-- Once again, researchers at Penn's Abramson Cancer Center have extended the reach of the immune system in the fight against ...
PHILADELPHIA -The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with ...
At least 100 of those reported deaths were linked to pancreatic cancer. Clinical trials for both Victoza and Saxenda raised concerns -- still unresolved ...
Nigerian Herbal Drug Can Cure Cancer – American Researchers ... the growth of cancer cells by 75 per cent in lung, colon and pancreatic cancers.
“And it is not just melanoma, with good data emerging in lung cancer, bladder cancer, head and neck cancer showing some promise.” Runcorn ...
Science Daily Cancer News
Poorer outcomes for African-American women with estrogen-receptor positive breast cancer, compared with European-American patients, appears to be due, in part, to a strong survival mechanism within the cancer cells, according to a study.
Breast cancer patients often display mild cognitive defects even before the initiation of chemotherapy. A new study now attributes the syndrome to post-traumatic stress induced by diagnosis of the disease.
Using a novel methodology of epigenetic quantitative analysis, investigators found no correlation between regulatory T cells and survival in the tumor microenvironment or blood, even when adjusting for well-known prognostic factors.
A skin cell responsible for scarring, and a molecule that inhibits the cell's activity, have been identified by researchers. The researchers also found that the cell may play a role in the growth of melanoma and in skin damage caused by radiation. A drug that acts in the same way as the inhibitory molecule is already approved for use in humans as a treatment for type-2 diabetes, so it could potentially move quickly into clinical trials for the treatment of scarring and melanoma, they say.
Tambahkan Komentar